The search term 'MYELOMA' revealed the following 4 open trials:
Trial Number: 09259 | Study Title: A Prospective Observational Study of Health-Related Quality of Life, Physical Function and Respiratory Function in Patients with Myeloma Affecting the Spine: The Impact of Disease, the Incidence of Fractures and the Effect of Vertebral Augmentation with Kyphoplasty |
Trial Number: 09252 | Study Title: An Open-label, Single-Arm, Phase 2 Study of Extended Carfilzomib Therapy in Subjects Previously Enrolled in Carfilzomib Treatment Protocols |
Trial Number: 09258 | Study Title: A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Added to the Combination of Bortezomib and Dexamethasone in Multiple Myeloma Patients Previously Treated with Bortezomib |
Trial Number: 08257 | Study Title: A Phase III, Randomized, Open-Label, 3-Arm Study to Determine the Efficacy and Safety of Lenalidomide (Revlimid) plus Low-Dose Dexamethasone When Given Until Progressive Disease or For 18 Four-Week Cycles Versus the Combination of Melphalan, Prednisone and Thalidomide Given for 12 Six-Week Cycles in Patients with Previously Untreated Multiple Myeloma Who are Either 65 Years of Age or Older or Not Candidates for Stem Cell Transplantation |
